Patients with a rare and deadly form of blood cancer have been 'given a second chance' after being given a 'game changing' new drug. The revolutionary treatment, known as Avapritinib, has now been ...
Updating peak systemic mastocytosis franchise revenue opportunity to $4 billion, catalyzed by strong AYVAKIT® (avapritinib) launch and evolving SM prevalence estimates -- -- Expect to achieve ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback